Precision Medicine Group
Evidence Solutions is seeking a motivated Analyst to join its growing team, ideal for recent graduates and early-career professionals interested in solving complex problems and translating insights into client recommendations. The role involves conducting research, performing analyses, and supporting the development of strategic recommendations across various market access and commercial strategy projects. Successful candidates will collaborate with experienced healthcare consultants to address critical business questions and develop client-ready presentations.
Headquarters
Bethesda, Maryland, United States
Company Size
1001-5000 employees
Founded
2012
Precision Medicine Group (PMG) is a consulting and solutions firm that helps pharmaceutical and life‑science companies accelerate drug development and improve patient outcomes by applying the discipline of precision medicine. PMG brings together specialized expertise in data and evidence generation, manufacturing, market access, and stakeholder engagement to unlock insights and speed commercialization. Focused on delivering measurable value, the company partners with innovators to advance development, strengthen access, and "move science closer to health."
Precision Medicine Group Announces Appointment of Tracey Leahy as Chief People Officer
Sep 16, 2025
Precision Medicine Group appoints Tracey Leahy as Chief People Officer
Sep 18, 2025
Precision Medicine Group Appoints Chief Information and Technology Officer
Apr 16, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Precision Medicine Group.
Precision Medicine Group Names Pharma Services Innovator, Eric Hodgins, as Chief Information and Technology Officer
Apr 16, 2025